EF

Euan Alexander Fraser Fordyce

CL Cancer Research Technology Limited: 2 patents #15 of 82Top 20%
AV Abb Vie: 1 patents #29 of 115Top 30%
RE Respivert: 1 patents #1 of 5Top 20%
Overall (2023): #48,898 of 537,848Top 10%
4
Patents 2023

Issued Patents 2023

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11767310 Nicotinamide RIPK1 inhibitors Kevin P. Cusack, Michael Z. Hoemann, David Kinsman, Sami Osman, James Stambuli +4 more 2023-09-26
11661423 Heterocyclic compounds as RET kinase inhibitors Allan Jordan, Rebecca Newton, Bohdan Waszkowycz, Jonathan Mark Sutton, George Hynd +1 more 2023-05-30
11634406 Inhibitor of p38 MAP kinase Alistair Ian Longshaw, Stuart Thomas Onions, John King-Underwood, Jennifer D. Venable 2023-04-25
11548896 Heterocyclic compounds as RET kinase inhibitors Allan Jordan, Rebecca Newton, Bohdan Waszkowycz, Jonathan Mark Sutton, George Hynd +1 more 2023-01-10